J. Welsh

发表

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

D. Klonoff, R. Slover, S. Garg, 2013, The New England journal of medicine.

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

George Dailey, John B Buse, William V Tamborlane, 2010, The New England journal of medicine.

Retrospective Analysis of Continuous Glucose Monitoring Data With the Surveillance Error Grid Supports Nonadjunctive Dosing Decisions

D. Price, J. Welsh, T. Walker, 2017, Journal of diabetes science and technology.

Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery

David C Klonoff, Bruce W Bode, Timothy S Bailey, 2015, Journal of diabetes science and technology.

The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia

D. Klonoff, B. Buckingham, R. Slover, 2011, Journal of diabetes science and technology.

Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the STAR 3 study.

J. Welsh, R. Tanenberg, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Feasibility of Adjacent Insulin Infusion and Continuous Glucose Monitoring via the Medtronic Combo-Set

A. Jenkins, D. O'Neal, G. Ward, 2013, Journal of Diabetes Science and Technology.

Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting

K. Nørgaard, H. Gjessing, J. Welsh, 2015, Journal of diabetes science and technology.

Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor.

N. C. Bhavaraju, John B Welsh, J. Welsh, 2017, Diabetes technology & therapeutics.

The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.

P. Calhoun, J. Welsh, T. Walker, 2018, Diabetes technology & therapeutics.

Upcoming Devices for Diabetes Management: The Artificial Pancreas as the Hallmark Device.

Scott W. Lee, J. Welsh, 2015, Diabetes technology & therapeutics.

Accuracy of the Sof-Sensor Glucose Sensor with the iPro Calibration Algorithm

F. Kaufman, Scott W. Lee, J. Welsh, 2012, Journal of diabetes science and technology.

Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study

Michael A. Wood, John B. Welsh, George Dailey, 2011, Diabetes Care.

Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.

Y. Kudva, T. Battelino, J. Buse, 2012, Diabetes technology & therapeutics.

Project Baiterek: A Patient Access Program to Improve Clinical Outcomes and Quality of Life in Children with Type 1 Diabetes in Kazakhstan.

F. Kaufman, J. Smith-Palmer, W. Valentine, 2015, Value in health regional issues.

Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes

D. Price, Xiaohe Zhang, J. Welsh, 2018, Journal of diabetes science and technology.

Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.

D. Klonoff, B. Buckingham, R. Slover, 2014, Diabetes technology & therapeutics.

Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.

J. Welsh, 2018, Diabetes technology & therapeutics.

Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts

J. Welsh, H. Akturk, G. Acciaroli, 2021, Journal of diabetes science and technology.

Manufacturing Process Changes and Reduced Skin Irritations of an Adhesive Patch Used for Continuous Glucose Monitoring Devices

J. Welsh, Vitaliy Gisin, Anna Chan, 2018, Journal of diabetes science and technology.

Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems

Xiaohe Zhang, J. Welsh, Andrew K. Balo, 2022, Journal of diabetes science and technology.

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

S. Garg, T. Bailey, Stayce E. Beck, 2022, Diabetes technology & therapeutics.

Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range

Joost H. van der Linden, I. Hirsch, S. Garg, 2021, Diabetes Technology & Therapeutics.

Glucose Monitoring and Diabetes Management in the Time of Coronavirus Disease 2019

D. Cherñavvsky, J. Welsh, T. Walker, 2020, Journal of diabetes science and technology.

Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth

Andrew S. Parker, M. Derdzinski, J. Welsh, 2019, Diabetes Therapy.

Threshold insulin-pump interruption to reduce hypoglycemia.

John J. Shin, R. Bergenstal, J. Welsh, 2013, The New England journal of medicine.

Acceptability and Utility of the mySentry Remote Glucose Monitoring System

B. Buckingham, R. Slover, J. Welsh, 2013, Journal of diabetes science and technology.

User Acceptability and Perceived Benefits of New Reports in CareLink Pro 3.0 Therapy Management Software for Diabetes

F. Kaufman, Scott W. Lee, J. Welsh, 2012, Journal of diabetes science and technology.

Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database.

Rajiv V Shah, F. Kaufman, J. Welsh, 2010, Pediatric endocrinology reviews : PER.

Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems

Mark Derdzinski, John B. Welsh, M. Derdzinski, 2019, Diabetes technology & therapeutics.

Effectiveness of sensor‐augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study

R. Slover, W. Tamborlane, M. A. Wood, 2012, Pediatric diabetes.

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase

Michael A. Wood, John B. Welsh, Stephen N. Davis, 2013 .

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

David C Klonoff, Bruce A Buckingham, Timothy S Bailey, 2012, Diabetes technology & therapeutics.

Associations between HbA1c and continuous glucose monitoring‐derived glycaemic variables

P. Calhoun, I. Hirsch, D. Price, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Real-time CGM (rtCGM) during the COVID-19 Pandemic and its Impact on Time in Range.

Joost H. van der Linden, I. Hirsch, S. Garg, 2021, Diabetes technology & therapeutics.

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

S. Garg, T. Bailey, John J. Shin, 2015, Diabetes technology & therapeutics.

Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps.

Rajiv V Shah, F. Kaufman, J. Welsh, 2015, Diabetes technology & therapeutics.

Assessing non‐adjunctive CGM safety at home and in new markets (ANSHIN)

P. Calhoun, J. Welsh, T. Walker, 2023, Endocrinology, diabetes & metabolism.

Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views

Andrew S. Parker, D. Price, M. Derdzinski, 2020, Journal of Diabetes Science and Technology.

391-P: Hypoglycemia Reductions with the Dexcom G6 CGM System’s Predictive Alert

Andrew S. Parker, M. Derdzinski, J. Welsh, 2019, Diabetes.

Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert

Andrew S. Parker, D. Price, M. Derdzinski, 2019, Diabetes technology & therapeutics.

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor.

Ronald Brazg, Timothy S Bailey, Mark Christiansen, 2014, Diabetes technology & therapeutics.

Association between attendance at an American diabetes camp and improvements in glycaemic control and treatment satisfaction

David Alfego, Kendra L. Magyar, J. Welsh, 2021, Endocrinology, diabetes & metabolism.

Safety and Functional Integrity of Continuous Glucose Monitoring Components After Simulated Radiologic Procedures

Christopher Thomas, John B Welsh, Spencer Lu, 2020, Journal of diabetes science and technology.

Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump

John B. Welsh, Pratik Agrawal, Pratik Choudhary, 2016, Diabetes technology & therapeutics.

Practical Considerations in the Use of Real-Time Continuous Glucose Monitoring Alerts

John B. Welsh, J. Mastrototaro, Scott W. Lee, 2010, Journal of diabetes science and technology.

NEW THERAPIES IN TYPE 1 DIABETES Inflammatory markers are increased in youth with type 1 diabetes : the SEARCH case – control study

R. Hovorka, L. Chassin, M. Wilinska, 2011 .

ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia

D. Klonoff, R. Slover, S. Garg, 2013, Journal of diabetes science and technology.

Effectiveness of sensor‐augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study

R. Slover, W. Tamborlane, M. A. Wood, 2012, Pediatric diabetes.

Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump

Sina Askari, John B. Welsh, Pratik Agrawal, 2011, Journal of diabetes science and technology.

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

D. Klonoff, R. Slover, S. Garg, 2013, The New England journal of medicine.

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

D. Klonoff, B. Buckingham, R. Slover, 2012, Diabetes technology & therapeutics.

Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management

B. Olsen, John J. Shin, I. Conget, 2016, Diabetes technology & therapeutics.

Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting

K. Nørgaard, H. Gjessing, J. Welsh, 2015, Journal of diabetes science and technology.